全文获取类型
收费全文 | 150428篇 |
免费 | 14142篇 |
国内免费 | 4166篇 |
专业分类
耳鼻咽喉 | 1612篇 |
儿科学 | 3316篇 |
妇产科学 | 2337篇 |
基础医学 | 25404篇 |
口腔科学 | 4054篇 |
临床医学 | 9525篇 |
内科学 | 23198篇 |
皮肤病学 | 2478篇 |
神经病学 | 14372篇 |
特种医学 | 5351篇 |
外国民族医学 | 33篇 |
外科学 | 18206篇 |
综合类 | 13787篇 |
现状与发展 | 17篇 |
一般理论 | 1篇 |
预防医学 | 6749篇 |
眼科学 | 1581篇 |
药学 | 19869篇 |
51篇 | |
中国医学 | 4761篇 |
肿瘤学 | 12034篇 |
出版年
2023年 | 2360篇 |
2022年 | 3394篇 |
2021年 | 6652篇 |
2020年 | 5640篇 |
2019年 | 6840篇 |
2018年 | 6547篇 |
2017年 | 5859篇 |
2016年 | 5184篇 |
2015年 | 5712篇 |
2014年 | 8750篇 |
2013年 | 9130篇 |
2012年 | 7687篇 |
2011年 | 8999篇 |
2010年 | 7193篇 |
2009年 | 7261篇 |
2008年 | 7110篇 |
2007年 | 6188篇 |
2006年 | 5449篇 |
2005年 | 4880篇 |
2004年 | 4178篇 |
2003年 | 3750篇 |
2002年 | 2755篇 |
2001年 | 2421篇 |
2000年 | 2072篇 |
1999年 | 1952篇 |
1998年 | 1799篇 |
1997年 | 1713篇 |
1996年 | 1541篇 |
1995年 | 1389篇 |
1994年 | 1273篇 |
1993年 | 1139篇 |
1992年 | 917篇 |
1991年 | 820篇 |
1990年 | 703篇 |
1989年 | 619篇 |
1988年 | 593篇 |
1986年 | 645篇 |
1985年 | 1752篇 |
1984年 | 2479篇 |
1983年 | 1654篇 |
1982年 | 1761篇 |
1981年 | 1653篇 |
1980年 | 1417篇 |
1979年 | 1227篇 |
1978年 | 1013篇 |
1977年 | 859篇 |
1976年 | 977篇 |
1975年 | 666篇 |
1974年 | 577篇 |
1973年 | 619篇 |
排序方式: 共有10000条查询结果,搜索用时 507 毫秒
91.
92.
93.
94.
95.
Extensive research has indicated that miRNAs are crucial for the occurrence and progression of cancers. miR-451a, involved in breast cancer (BC), is one of the miRNAs. This study focused on the mechanism by which miR-451a regulates BC. The levels of miR-451a in BC tissues and cell lines were examined using quantitative real-time polymerase chain reaction (qRT-PCR). Kaplan‒Meier analysis showed that this was intimately related to the patient's overall survival rate. Functional experiments revealed the negative effects of miR-451a on the abilities of BC cells to multiply (tested by Cell Counting Kit-8), migrate (tested by wound healing assay), and invade (tested by Transwell assay) and its positive effects on apoptosis (tested by flow cytometry). Western blotting indicated that the expression of tumor-related proteins was affected by miR-451a. Moreover, in vivo experiments suggested that tumor growth was clearly restrained by an miR-451a agonist in a xenograft tumor model. Bioinformatic analysis indicated that miR-451a directly targeted Cyclin D2 (CCND2), as demonstrated by the luciferase reporter assay. An opposite change in the level of CCND2 and miR-451a in BC was indicated by qRT-PCR, western blotting, and immunohistochemistry. Subsequently, functional experiments and western blotting analysis confirmed that CCND2 accelerated BC progression, which was regulated by miR-451a. Cumulatively, research on miR-451a may be valuable for BC treatment. 相似文献
96.
97.
98.
99.
Fei Xu Ming‐Liang Ye Yu‐Peng Zhang Wen‐Jie Li Meng‐Ting Li Hai‐Zhou Wang Xiao Qiu Yan Xu Jin‐Wen Yin Qian Hu Wan‐Hui Wei Ying Chang Lan Liu Qiu Zhao 《Cancer science》2020,111(5):1528-1541
Resistance to chemotherapy is a major challenge for the treatment of patients with colorectal cancer (CRC). Previous studies have found that microRNAs (miRNAs) play key roles in drug resistance; however, the role of miRNA‐373‐3p (miR‐375‐3p) in CRC remains unclear. The current study aimed to explore the potential function of miR‐375‐3p in 5‐fluorouracil (5‐FU) resistance. MicroRNA‐375‐3p was found to be widely downregulated in human CRC cell lines and tissues and to promote the sensitivity of CRC cells to 5‐FU by inducing colon cancer cell apoptosis and cycle arrest and by inhibiting cell growth, migration, and invasion in vitro. Thymidylate synthase (TYMS) was found to be a direct target of miR‐375‐3p, and TYMS knockdown exerted similar effects as miR‐375‐3p overexpression on the CRC cellular response to 5‐FU. Lipid‐coated calcium carbonate nanoparticles (NPs) were designed to cotransport 5‐FU and miR‐375‐3p into cells efficiently and rapidly and to release the drugs in a weakly acidic tumor microenvironment. The therapeutic effect of combined miR‐375 + 5‐FU/NPs was significantly higher than that of the individual treatments in mouse s.c. xenografts derived from HCT116 cells. Our results suggest that restoring miR‐375‐3p levels could be a future novel therapeutic strategy to enhance chemosensitivity to 5‐FU. 相似文献
100.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献